Jing Tan

机构：Kunming Medical University, Yunnan Center for Disease Control And Prevention, Yan'an Hospital Affiliated To Kunming Medical University · ORCID：0009-0001-3443-4419

发表论文 32 篇 · 总被引 402 次 · h-index 10

代表论文

• Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury (2018 · Journal of the American Society of Nephrology · 被引 141)
• IL-25 Elicits Innate Lymphoid Cells and Multipotent Progenitor Type 2 Cells That Reduce Renal Ischemic/Reperfusion Injury (2015 · Journal of the American Society of Nephrology · 被引 91)
• GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling (2021 · Cancer Letters · 被引 46)
• Up-regulation of S100A4 expression by HBx protein promotes proliferation of hepatocellular carcinoma cells and its correlation with clinical survival (2020 · Gene · 被引 19)
• Retrospective analysis of the efficacy of adjuvant cytokine‐induced killer cell immunotherapy combined with chemotherapy in colorectal cancer patients after surgery (2022 · Clinical & Translational Immunology · 被引 15)
• Update on Chemoresistance Mechanisms to First-Line Chemotherapy for Gallbladder Cancer and Potential Reversal Strategies (2023 · American Journal of Clinical Oncology · 被引 14)